scholarly journals Integrative review: postcraniotomy pain in the brain tumour patient

2016 ◽  
Vol 72 (6) ◽  
pp. 1221-1235 ◽  
Author(s):  
Rebecca Elizabeth Guilkey ◽  
Diane Von Ah ◽  
Janet S. Carpenter ◽  
Cynthia Stone ◽  
Claire B. Draucker
Keyword(s):  
Brain Tumour ◽  
Integrative Review ◽  
Brain Tumour Patient ◽  
Tumour Patient ◽  
The Brain

scholarly journals Development of a Multidisciplinary Brain Tumour Patient Passport

2017 ◽  
Vol 17 (5) ◽  
pp. 210 ◽  
Author(s):  
Kareena Malone ◽  
Ann Lynch Pope ◽  
Eloise Cowie ◽  
Eithne Dunne
Keyword(s):  
Brain Tumour ◽  
Brain Tumour Patient ◽  
Tumour Patient

Severe Head Injury linked to Subsequent Development of Malignant Brain Tumour within a Short Period- A Case Report

2018 ◽  
Vol 3 (2) ◽  
Keyword(s):  
Head Injury ◽  
Brain Tumour ◽  
Severe Head Injury ◽  
Case Reports ◽  
Subsequent Development ◽  
Malignant Brain Tumour ◽  
Tumour Development ◽  
Short Period ◽  
The Brain

There have been a few case reports of head injury leading to brain tumour development in the same region as the brain injury. Here we report a case where the patient suffered a severe head injury with contusion. He recovered clinically with conservative management. Follow up Computed Tomography scan of the brain a month later showed complete resolution of the lesion. He subsequently developed malignant brain tumour in the same region as the original contusion within a very short period of 15 months. Head injury patients need close follow up especially when severe. The link between severity of head injury and malignant brain tumour development needs further evaluation. Role of anti-inflammatory agents for prevention of post traumatic brain tumours needs further exploration.

scholarly journals Single-cell resolution in high-resolution synchrotron X-ray CT imaging with gold nanoparticles

2013 ◽  
Vol 21 (1) ◽  
pp. 242-250 ◽  
Author(s):  
Elisabeth Schültke ◽  
Ralf Menk ◽  
Bernd Pinzer ◽  
Alberto Astolfo ◽  
Marco Stampanoni ◽  
...  
Keyword(s):  
Gold Nanoparticles ◽  
Single Cell ◽  
Brain Tumour ◽  
Ex Vivo ◽  
Small Animal ◽  
C6 Glioma Cells ◽  
X Ray ◽  
Local Tomography ◽  
The Brain

Gold nanoparticles are excellent intracellular markers in X-ray imaging. Having shown previously the suitability of gold nanoparticles to detect small groups of cells with the synchrotron-based computed tomography (CT) technique bothex vivoandin vivo, it is now demonstrated that even single-cell resolution can be obtained in the brain at leastex vivo. Working in a small animal model of malignant brain tumour, the image quality obtained with different imaging modalities was compared. To generate the brain tumour, 1 × 105C6 glioma cells were loaded with gold nanoparticles and implanted in the right cerebral hemisphere of an adult rat. Raw data were acquired with absorption X-ray CT followed by a local tomography technique based on synchrotron X-ray absorption yielding single-cell resolution. The reconstructed synchrotron X-ray images were compared with images obtained by small animal magnetic resonance imaging. The presence of gold nanoparticles in the tumour tissue was verified in histological sections.

Gliomatosis Cerebri: A Brain Tumour Which is too Difficult to Treat?

1998 ◽  
Vol 43 (3) ◽  
pp. 84-86 ◽  
Author(s):  
D. Choi ◽  
U. Schulz ◽  
K. Seex
Keyword(s):  
Brain Tumour ◽  
Clinical Symptoms ◽  
Ct Scanning ◽  
Mass Effect ◽  
World Health Organisation ◽  
Gliomatosis Cerebri ◽  
World Health ◽  
Low Grade ◽  
The Brain ◽  
Diffuse Brain

Gliomatosis cerebri is a rare form of primary diffuse brain tumour first described by Nevin in 1938.1 It was originally considered to be a post-mortem diagnosis before Troost et al reported a clinically diagnosed case in 1987.2 However antemortem diagnosis remains difficult due to vague clinical symptoms and often non-specific findings on CT scanning. Gliomatosis cerebri has been classified by the World Health Organisation as an infiltrative tumoural process, which involves at least two, and usually three, lobes of the brain.3 Magnetic resonance (MR) imaging shows a diffuse infiltrative process with possible mass effect but no necrosis. histology is usually of a low grade astrocytic neoplasm which seemingly infiltrates out of proportion to the degree of anaplasia. We report two patients who presented over the past year, whose clinical and radiological features prompted a preoperative diagnosis of gliomatosis cerebri, confirmed by biopsy.

scholarly journals Using surgical and oncology workload to plan brain tumour trial recruitment in England

2019 ◽  
Vol 21 (Supplement_4) ◽  
pp. iv11-iv12
Author(s):  
Kerlann Le Calvez ◽  
Peter Treasure ◽  
Matt Williams
Keyword(s):  
Clinical Trials ◽  
Brain Tumour ◽  
Brain Tumours ◽  
Adult Patients ◽  
Trial Recruitment ◽  
Trade Off ◽  
Primary Brain Tumour ◽  
Rational Planning ◽  
The Brain ◽  
Over Time

Abstract Introduction Access to clinical trials is a common request for patients with brain tumours. However, opening clinical trials requires additional work per centre opened. We have previously shown that surgical and oncology workload varies between centres, and fluctuates over time. There is a trade-off between offering access to clinical trials and increasing costs associated with opening trials in centres that treat few patients. Methods We used two separate datasets from England covering 3 years – one for neurosurgical workload and one for radiotherapy. We only included adult patients and calculated cumulative proportions of the malignant primary brain tumour population (C71) by number of centres. We investigated stability by checking how many patients would have to be added/ removed from a centre to change their rank. Results There were 7061 surgical and 5060 radiotherapy patients. To capture 25% of patients, we would need to open trials in 4 surgical/5 radiotherapy centres; for 50%, 9 surgical/ 13 radiotherapy centres; for 75%, 16 surgical/ 24 radiotherapy centres. Centre rank was fluid: adding 16 surgical/9 radiotherapy patients would change the rank of a centre. Discussion These are the first data to allow for rational planning of trials in brain tumour patients. We have shown that we can reach 75% of the brain tumour population by opening trials in ~50% of surgical and radiotherapy centres. Centre rank alters over year, so we should be cautious about being too prescriptive. Nonetheless, these data should allow some rational planning of trial centre inclusion.

Recurrent bilateral frontal lobe lesion with maladaptive schema modes and PTSD symptoms: a case study

2020 ◽  
pp. 1-8
Author(s):  
Sabir Zaman ◽  
Kehkashan Arouj ◽  
Shahid Irfan
Keyword(s):  
Frontal Lobe ◽  
Ptsd Symptoms ◽  
Post Traumatic Stress ◽  
Schema Modes ◽  
Brain Tumour Patient ◽  
Post Traumatic ◽  
And Coping ◽  
Tumour Patient ◽  
Frontal Lobe Lesion

Abstract The frontal lobe is responsible for high-order functioning, such as memory, attention, decision-making, and personality. Lesions in the frontal lobe may lead to different physical and psychological problems. The current study was conducted to examine the emotional, cognitive, and behavioural states and coping strategies of a patient with recurrent bilateral frontal lobe lesion. It also attempted to determine post-traumatic stress disorder (PTSD) symptoms in a patient. This study described the case of an adult with recurrent bilateral frontal lobe tumour. It covered the clinical presentation, administration of Urdu translation of the Schema Mode Inventory (SMI) and Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), and analysis of the case. The results of the study showed that the recurrent bilateral frontal lobe brain tumour patient engaged in child mode and had a dysfunctional coping style and a maladaptive punitive parent mode. Furthermore, the patient also had moderate PTSD symptoms. Continuous....

Sign in / Sign up

Export Citation Format

Share Document